Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122476712 | 12247671 | 2 | F | 199201 | 20160802 | 20160408 | 20160812 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-023376 | BRISTOL MYERS SQUIBB | 35.30 | YR | M | Y | 92.99000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122476712 | 12247671 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 5 MG, UNK | N | U | 9218 | 5 | MG | INJECTION | |||||
| 122476712 | 12247671 | 2 | SS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 70 MG, QWK | N | U | 9218 | 70 | MG | INJECTION | /wk | ||||
| 122476712 | 12247671 | 3 | SS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 1 DF, QWK | N | U | 9218 | 1 | DF | INJECTION | /wk | ||||
| 122476712 | 12247671 | 4 | I | DILANTIN | PHENYTOIN | 1 | Unknown | 100 MG, TID | 0 | 100 | MG | TID | |||||||
| 122476712 | 12247671 | 5 | C | LYRICA | PREGABALIN | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
| 122476712 | 12247671 | 6 | C | LYRICA | PREGABALIN | 1 | U | 0 | TABLET | ||||||||||
| 122476712 | 12247671 | 7 | C | DIOVAN | VALSARTAN | 1 | Unknown | 160 MG, QD | U | 0 | 160 | MG | QD | ||||||
| 122476712 | 12247671 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 UNIT, QD | U | 0 | 1000 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122476712 | 12247671 | 1 | Antiphospholipid syndrome |
| 122476712 | 12247671 | 2 | Antiphospholipid syndrome |
| 122476712 | 12247671 | 4 | Seizure |
| 122476712 | 12247671 | 5 | Seizure |
| 122476712 | 12247671 | 6 | Neuropathy peripheral |
| 122476712 | 12247671 | 7 | Blood pressure management |
| 122476712 | 12247671 | 8 | Hypocalcaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122476712 | 12247671 | OT |
| 122476712 | 12247671 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122476712 | 12247671 | Antibody test positive | |
| 122476712 | 12247671 | Cerebrovascular accident | |
| 122476712 | 12247671 | Dizziness | |
| 122476712 | 12247671 | International normalised ratio increased | |
| 122476712 | 12247671 | Labelled drug-drug interaction medication error | |
| 122476712 | 12247671 | Myocardial infarction | |
| 122476712 | 12247671 | Protein S deficiency | |
| 122476712 | 12247671 | Seizure | |
| 122476712 | 12247671 | Thrombosis | |
| 122476712 | 12247671 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122476712 | 12247671 | 4 | 1989 | 0 |